FoleyR.N., ParfreyP.S., SarnakM.J.Clinical epidemiology of cardiovascular disease in chronic renal disease.Am J Kidney Dis1998; 32(5 Suppl 3): S112–19.
2.
KanbayM., AfsarB., Gusbeth-TatomirP., CovicA.Arterial stiffness in dialysis patients: where are we now?Int Urol Nephrol2009 Nov 19; epub ahead of print: PMID 1992 4558.
3.
HanS.S., AhnJ.M., ChinH.J., ChaeD.W., OhK.H., JooK.W.Impact of C-reactive protein and pulse pressure evaluated at the start of peritoneal dialysis on cardiovascular events in the course of treatment with peritoneal dialysis.Perit Dial Int2010; 30: 300–10.
4.
StenvinkelP.Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure.Blood Purif2001; 19: 143–51.
5.
KaysenG.A.C-reactive protein. A story half told.Semin Dial2000; 13: 143–6.
6.
YeunJ.Y., LevineR.A., MantadilokV., KaysenG.A.C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients.Am J Kidney Dis2000; 35: 469–76.
7.
WannerC., ZimmermannJ.What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients?Semin Dial2000; 13: 174–5.
8.
Simic-OgrizovicS., DopsajV., Bogavac-StanojevicN., ObradovicI., StosovicM., RadovicM.Serum amyloid-A rather than C-reactive protein is a better predictor of mortality in hemodialysis patients.Tohoku J Exp Med2009; 219: 121–7.
9.
WetmoreJ.B., LovettD.H., HungA.M., Cook-WiensG., MahnkenJ.D., SenS.Associations of interleukin-6, C-reactive protein and serum amyloid A with mortality in haemodialysis patients.Nephrology (Carlton)2008; 13: 593–600.
10.
PanichiV., MaggioreU., TaccolaD., MiglioriM., RizzaG.M., ConsaniC.Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients.Nephrol Dial Transplant2004; 19: 1154–60.
11.
RidkerP.M., NennekensC.H., BuringJ.E., RifaiN.C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.N Engl J Med2000; 342: 836–43.
12.
RidgerP.M., StampferM.J., RifaiN.Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.JAMA2001; 285: 2481–5.
13.
StenvinkelP., HeimbürgerO., PaultreF., DiczfalusyU., WangT., BerglundL.Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.Kidney Int1999; 55: 1899–911.
14.
ZoccaliC., BenedettoF.A., MallamaciF., TripepiG., FermoI., FocaA.Inflammation is associated with carotid atherosclerosis in dialysis patients.J Hypertens2000; 18: 1207–13.
15.
WangA.Y., HoS.S., LiuE.K., ChanI.H., HoS., SandersonJ.E.Differential associations of traditional and non-traditional risk factors with carotid intima-media thickening and plaque in peritoneal dialysis patients.Am J Nephrol2007; 27: 458–65.
16.
WangA.Y., WooJ., WangM., SeaM.M., IpR., LiP.K.Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients.J Am Soc Nephrol2001; 12: 1927–36.
17.
SchlieperG., BrandenburgV., DjuricZ., DamjanovicT., MarkovicN., SchurgersL.Risk factors for cardiovascular calcifications in non-diabetic Caucasian haemodialysis patients.Kidney Blood Press Res2009; 32: 161–8.
18.
BergströmJ., HeimbürgerO., LindholmB., QureshiA.R.Elevated serum C-reactive protein is a strong predictor of increased mortality and low serum albumin in haemodialysis (HD) patients [Abstract].J Am Soc Nephrol1995; 6: 573.
19.
ZimmermannJ., HerrlingerS., PruyA., MetzgerT., WannerC.Inflammation enhances cardiovascular risk and mortality in haemodialysis patients.Kidney Int1999; 55: 648–58.
20.
IsekiK., TozawaM., YoshiS., FukiyamaK.Serum C-reactive (CRP) and risk of death in chronic dialysis patients.Nephrol Dial Transplant1999; 14: 1956–60.
21.
Panichi V, Rizza GM, Paoletti S, Bigazzi R, Aloisi M, Barsotti G, et al; RISCAVID Study Group.Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID Study.Nephrol Dial Transplant2008; 23: 2337–43.
22.
Krane V, Winkler K, Drechsler C, Lilienthal J, März W, Wanner C; German Diabetes and Dialysis Study Investigators.Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.Am J Kidney Dis2009; 54: 902–11.
23.
HaubitzM., BrunkhorstR.C-reactive protein and chronic Chlamydia pneumoniae infection—long term predictors of cardio-vascular disease survival in patients on peritoneal dialysis.Nephrol Dial Transplant2001; 16: 809–15.
24.
NohH., LeeS.W., KangS.W., ShinS.K., ChoiK.H., LeeH.Y.Serum C-reactive protein: a predictor of mortality in continuous ambulatory peritoneal dialysis patients.Perit Dial Int1998; 18: 387–94.
25.
ChungS.H., LindholmB., LeeH.B.Influence of initial nutritional status on continuous ambulatory peritoneal dialysis patient survival.Perit Dial Int2000; 20: 19–26.
26.
DuclouxD., Bresson-VautrinC., KribsM., AbdelfatahA., ChalopinJ-MC-reactive protein and cardiovascular disease in peritoneal dialysis patients.Kidney Int2002; 62: 1417–22.
27.
HerzigK.A., PurdieD.M., ChangW., BrownA.M., HawleyC.M., CampbellS.B.Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?J Am Soc Nephrol2001; 12: 814–21.
28.
AvramM.M., FeinP.A., PaluchM.M., SchlothT., ChattopadhyayJ.Association between C-reactive protein and clinical outcomes in peritoneal dialysis patients.Adv Perit Dial2005; 21: 154–8.
29.
AvramM.M., FeinP.A., RafiqM.A., SchlothT., ChattopadhyayJ., MittmanN.Malnutrition and inflammation as predictors of mortality in peritoneal dialysis patients.Kidney Int Suppl2006; 104: S4–7.
30.
de Mutsert R, Grootendorst DC, Axelsson J, Boeschoten EW, Krediet RT, Dekker FW; NECOSAD Study Group.Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients.Nephrol Dial Transplant2008; 23: 2957–64.
31.
StenvinkelP.Inflammation in end-stage renal disease: the hidden enemy.Nephrology (Carlton)2006; 11: 36–41.
32.
Pérez-FloresI., CoronelF., CigarránS., HerreroJ.A., CalvoN.Relationship between residual renal function, inflammation, and anemia in peritoneal dialysis.Adv Perit Dial2007; 23: 140–3.
33.
WeiM., BargmanJ.M., OreopoulosD.G.Factors related to erythropoietin hypo-responsiveness in patients on chronic peritoneal dialysis.Int Urol Nephrol2007; 39: 935–40.
34.
FeinP.A., FazilI., RafiqM.A., SchlothT., MatzaB., ChattopadhyayJ.Relationship of peritoneal transport rate and dialysis adequacy with inflammation in peritoneal dialysis patients.Adv Perit Dial2006; 22: 2–6.
35.
KalenderB., OzdemirA.C., KorogluG.Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease.Nephron Clin Pract2006; 102: c115–21.
36.
StenvinkelP., ChungS.H., HeimburgerO., LindholmB.Malnutrition, inflammation and atherosclerosis in peritoneal dialysis patients.Perit Dial Int2001; 21(Suppl 3): S157–62.
37.
van EschS., ZweersM.M., JansenM.A., de WaartD.R., van ManenJ.G., KredietR.T.Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients.Perit Dial Int2004; 24: 554–61.
38.
RodriguesA.S., AlmeidaM., FonsecaI., MartinsM., CarvalhoM.J., SilvaF.Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation.Nephrol Dial Transplant2006; 21: 763–9.
39.
RumpsfeldM., McDonaldS.P., PurdieD.M., CollinsJ., JohnsonD.W.Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients.Am J Kidney Dis2004; 43: 492–501.
40.
WangT., HeimburgerO., ChengH.H., BergstromJ., LindholmB.Does a high peritoneal transport rate reflect a state of chronic inflammation?Perit Dial Int1999; 19: 17–22.
41.
Gusbeth-TatomirP., CovicA.Causes and consequences of increased arterial stiffness in chronic kidney disease patients.Kidney Blood Press Res2007; 30: 97–107.
42.
CovicA., Gusbeth-TatomirP., GoldsmithD.J.Arterial stiffness in renal patients: an update.Am J Kidney Dis2005; 45: 965–77.
43.
HaydarA.A., CovicA., ColhounH., RubensM., GoldsmithD.J.Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients.Kidney Int2004; 65: 1790–4.
44.
ChengL.T., TangL.J., ChenH.M., TangW., WangT.Relationship between serum albumin and pulse wave velocity in patients on continuous ambulatory peritoneal dialysis.Vasc Health Risk Manag2008; 4: 871–6.
45.
CovicA., Gusbeth-TatomirP., GoldsmithD.Negative outcome studies in end-stage renal disease: how dark are the storm clouds?Nephrol Dial Transplant2008; 23: 56–6.
